Is ImmunityBio, Inc. (IBRX) halal? Halal. Based on AAOIFI screening, ImmunityBio, Inc. passes both qualitative (business activity) and quantitative (financial ratio) screens with a compliance score of 88/100 (Grade: A).

ImmunityBio, Inc. logo

IBRX β€” Is ImmunityBio, Inc. Halal?

Halal

ImmunityBio, Inc.

NASDAQHealthcareUS

$7.23

-0.14%

About ImmunityBio, Inc.

ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The company also develops therapeutic agents, which are in Phase II or III clinical trial for the treatment of liquid and solid tumors, including bladder, pancreatic, and lung cancers, as well as pathogens as SARS-CoV-2 and HIV. It has collaboration agreements with National Cancer Institute, National Institute of Deafness and Communication Disorders, and Amyris, Inc.; and license agreements with CytRx Corporation, EnGeneIC Pty Limited, GlobeImmune, Inc., and Infectious Disease Research Institute, Sanford Health, Shenzhen Beike Biotechnology Co. Ltd., Sorrento Therapeutics, Inc., and Viracta Therapeutics, Inc. The company was founded in 2014 and is based in San Diego, California.

Sector: Healthcare Β· Industry: Biotechnology

Shariah Compliance Status

Based on AAOIFI screening standards

A

Very Good

Strong compliance across all metrics

88Score

Business Activity Screen

Passed

Checks if the business is involved in prohibited activities (alcohol, gambling, pork, conventional banking, etc.)

Financial Ratio Screen

Passed

Financial ratios must be below AAOIFI thresholds

Debt / Market Cap0.0% / 30.0%

Compliance History

  1. Halalnow

    since Jun 2026

  2. Not Halal

    until the change above

Tracked since Jun 2026. Updates automatically on each re-screen.

Screened: Jun 3, 2026Fiscal: 2026-2026-Q1Source: FMP

Purify Your IBRX Dividends

1.9% non-compliant income

IBRX has 1.9% prohibited income. Calculate exactly how much of your dividends to donate.

Financial Overview

Market Cap

7.6B

Price

$7.23

Sector

Healthcare

Industry

Biotechnology

Free β€” No credit card required

Track IBRX and 10,000+ stocks with AI insights

Create your free account to unlock AI-powered compliance analysis, track your portfolio, calculate purification, and get unlimited AAOIFI screening.

10,000+ assets AAOIFI standards Free watchlist

Disclaimer: This screening is for informational purposes only and does not constitute financial, legal, or religious advice. Compliance is evaluated using AAOIFI financial standards (debt, deposits, and prohibited income ratios) and publicly available data. Ethical, political, social, or environmental considerations are outside the scope of this screening. Individual scholars and methodologies may differ. Always consult a qualified Islamic finance advisor before making investment decisions.